Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease Journal:Health and Quality of Life Outcomes | 15-Aug-2023 | ||
Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based study in Hong Kong. The Endocrine Society’s 105th Annual Meeting, Chicago, June 2023. Proceeding/Conference:The Endocrine Society’s 105th Annual Meeting (15/06/2023-18/06/2023, Chicago) | 15-Jun-2023 |